However, these guidelines do not set any reference value for the 25(OH)D level, but recommend its evaluation in patients at stages of CKD above 3 with progressively increasing or persistently elevated (above upper normal) PTH levels. The gene discussed is PTH; the disease is chronic kidney disease.